Yingyyi Qin

A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion

W. Lau, W. Cong, Kang Wang, 2021, European Journal of Surgical Oncology.

Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study.

Kang Wang, Shuqun Cheng, Maolin Yan, 2022, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma

Kang Wang, Y. Shan, Yuqiang Cheng, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of Stereotactic Body Radiation Therapy in Patients With Pd-1 Inhibitor–transarterial Chemoembolization Refractory Intermediate-stage Hepatocellular Carcinoma: a Retrospective Controlled Study

Y. Zheng, Kang Wang, Shuqun Cheng, 2021 .

Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model

D. Xie, Xiao-Fan Wang, Hong-Yang Wang, 2011, Hepatology.

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Kang Wang, Jie Shi, Fan Zhang, 2024, Nature medicine.